Asia Pacific

Over 2023, digestive remedies is projected to see good retail volume growth and faster retail current value sales, supported by inflationary pressure on prices. The heightened stress and anxiety and a tendency among some consumers to overeat or fall…

Sales of digestive remedies continue to see a strong recovery in 2023 in current value terms. Sales are rebounding from the negative impact of the pandemic with the lifting of restrictions increasing the opportunities for consumers to go out to eat…

Diarrhoea is a common problem, but it is still the cause of many childhood deaths throughout the world, including in Indonesia. Apart from causing pain and even death, diarrhoea can also hinder a child’s growth and development, because it can cause…

Digestive remedies is set to see single-digit current value growth in 2023, primarily driven by the increasing trend of people eating at restaurants more frequently. This shift can be attributed to fast-paced urban lifestyles, which often leave…

With traveling restrictions and social distancing measures fully lifted, residents in Hong Kong were gradually resuming their normal social lives in 2023. This resulted in an increase dining out and social gatherings, with people now able to meet up…

In 2023, the prevalence of the XBB strain of COVID-19 in China, which typically presents with gastrointestinal discomfort and diarrhoea symptoms, has led to the rising popularity of digestive remedies, with the overall category set to achieve high…

Growth for digestive remedies in Azerbaijan is slow and steady in 2023. With the lifting of pandemic-related restrictions, there was a brief shot of adrenaline as people returned to the office and resumed their social lives. However, any expectation…

Retail value sales of dietary supplements continue to grow strongly in 2023, albeit at a marginally slower pace compared to the previous two years. The rising demand for dietary supplements has been significantly influenced by the pandemic when local…

During the pandemic, the popularity of dietary supplements skyrocketed as people sought preventative strategies to boost their immune health and minimise the impact of COVID-19. At this time, state customs officials actively promoted the import of…

Probiotic supplements generated further positive sales growth in 2023 as the category continued to recover from the significant sales declines registered in 2021. Many consumers began taking probiotic products as a way of strengthening their immune…

In 2023, Thailand witnessed a continued strong demand for dietary supplements, reflecting a heightened consumer interest in preventative health. While fears surrounding the COVID-19 pandemic had largely subsided, there remained a key focus on…

Overall volume sales of dietary supplements in Taiwan have picked up in 2023, with most categories set to show improved results in this regard as compared to 2022. As with vitamins, demand has been buoyed by the growing adoption of more holistic and…

Ginseng remains by far the largest value category within dietary supplements in South Korea. As ginseng is well-known for its overall immunity support, this category is experiencing stable demand, whilst also remaining popular for gifting, with red…

Aligned with increased health consciousness and the desire to ensure preventive health, dietary supplements is set to record significant growth in 2023. Combination dietary supplements is expected to continue to be the largest category within dietary…

Value sales for dietary supplements continue to be low in Pakistan and significantly lower than for vitamins. However, it is expected to register healthy growth in 2023, as wealthier consumers take increasingly take a preventative approach to their…

With COVID-19 still a relatively recent memory, Malaysians continued to place a strong emphasis on preventative health measures, including the intake of dietary supplements. Consumers saw these products as an effective way of boosting their immune…

Dietary Supplements in Kazakhstan remains an attractive proposition for manufacturers and distributors in 2023, as their prices are not regulated by the Tariff Regulatory Authority. Dietary supplements continues to grow healthily in retail volume and…

Similar to the pattern seen in vitamins, sales of dietary supplements continue to see steady growth in current value terms in 2023 due to increasing health consciousness. The market has been hit by the rising cost of raw materials and production…

In 2023, dietary supplements is only set to see low current value growth, but will maintain the gains seen during the pandemic. Meanwhile, although retail volume sales are expected to decline in around half the categories, this is after seeing a peak…

Dietary supplements has been experiencing significant growth in India, primarily owing to the growing challenge of maintaining a balanced diet in the face of increasingly hectic and sedentary lifestyles. As the pace of life accelerates and work…

2023 saw increased interest in women’s health and beauty supplements in Hong Kong as pandemic restrictions were removed, with more opportunities for consumers to go out and socialise. Female consumers are increasingly attracted to supplements with…

Dietary supplements is expected to register robust growth in China in 2023, after the easing of COVID-19-related restrictions. The surge in COVID-19 cases since the lifting of restrictions in late December 2022 brought health products such a dietary…

In dietary supplements in Azerbaijan, sales are seeing positive though slowed volume sale growth in 2023, buoyed by fierce competition among market players. However, there is a regulatory hurdle that is curbing growth potential, in that the…

Despite another positive performance by dermatologicals in 2023, the category is recording significantly slower growth rates compared to 2022. The dynamic growth in 2022 was due to the fact that after the lifting of restrictions in Vietnam, local…

Retail sales of dermatologicals showed moderate growth in current value terms in 2023, with inflationary pressures less severe but still a factor. The dermatological category in Uzbekistan is an area lacking in development, largely due to the limited…

2023 saw rising demand for dermatologicals supported by the return to pre-pandemic daily routines and lifestyles as greater exposure to the causes of various mild skin conditions resulted in a higher incidence of skin infections and parasite-related…

Retail sales of dermatological products in Thailand experienced accelerated growth in current value terms in 2023, following the return of consumers to more active lifestyles outside the home. With this increased mobility came a greater risk of…

As is the case across consumer health in Taiwan, herbal/traditional varieties have continued to gain popularity in dermatologicals in 2023 amidst rising awareness of the potentially harmful side effects and contraindications of active pharmaceutical…

Dermatologicals is a saturated category in South Korea and has lost some of its growth momentum in terms of retail volume sales. A lack of new product development is one factor hampering stronger growth for some products, whilst another is increasing…

The social restrictions in Singapore at the start of the pandemic led to less time spent outside the home, and therefore less concern about looks. This contributed to volume and current value declines for hair loss treatments and medicated shampoos…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…

Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…

The above-average, high single-digit current value growth expected in topical germicidals/antiseptics in 2023 is also driving growth within overall dermatologicals in India, as this is the largest category. This surge in sales has been driven by…

Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…

In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…

Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…

The report will explore the key themes transforming consumer behaviour in Asia Pacific in the world beyond the pandemic, namely Digital Living, Rethink Wellness, Sustainable Living, Make My Life Easier and Search for Experiences, and the strategies…

Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

Like analgesics, sales of cough, cold and allergy (hay fever) remedies continue to rise, benefiting from the “tripledemic” of rising COVID-19 cases, the stronger return of influenza due to greater mobility outside of the home and contact with others,…

The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…

As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…

Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…

Cough, cold and allergy (hay fever) remedies is experiencing a level of stabilisation in 2023. Following strong retail volume growth in the wake of the Coronavirus (COVID-19) pandemic, almost all categories are projected to see slower retail volume…